Diffusion imaging for evaluation of tumor therapies in preclinical animal models

Magnetic Resonance Materials in Physics, Biology and Medicine

Volumn 17, Issue 3-6, 2004, Pages 249-259

  Moffat, B A ^a   Hall, D E ^a   Stojanovska, J ^a   McConville, P J ^b   Moody, J B ^b   Chenevert, T L ^a   Rehemtulla, A ^a   Ross, B D ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Center for Molecular Imaging   (United States)

Author keywords

ADC; Apparent diffusion coefficient; Diffusion; MRI; NMR; Therapeutic efficacy; Tumor

Indexed keywords

CARMUSTINE; FLUCYTOSINE; FLUOROURACIL; IRINOTECAN;

BRAIN TUMOR; CANCER THERAPY; CORRELATION COEFFICIENT; DIAGNOSTIC IMAGING; DOSE RESPONSE; MEDICAL ASSESSMENT; MEDICAL TECHNOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CARCINOMA; REVIEW; SOLID TUMOR;

ANIMALS; ANTINEOPLASTIC AGENTS; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; IMAGE INTERPRETATION, COMPUTER-ASSISTED; NEOPLASMS; PROGNOSIS; TREATMENT OUTCOME;

ANIMALIA;

EID: 14944362960     PISSN: 09685243     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10334-004-0079-z     Document Type: Review

References (33)

1. Curt GA (1994) The use of animal models in cancer drug discovery and development. Stem Cells 12(1):23-29
2. Crafts D, Wilson CB (1977) Animal models of brain tumors. Natl Cancer Inst Monogr 46:11-17
3. Peterson DL, Sheridan PJ, Brown WE Jr (1995) Animal models for brain tumors: historical perspectives and future directions. J Neurosurg 80(5):865-876
4. Rosenblum ML, Knebel KD, Wheeler KT, Barker M, Wilson CB (1975) Development of an in vitro colony formation assay for the evaluation of in vivo chemotherapy of a rat brain tumor. In Vitro 11(5):264-273
5. Rosenblum ML, Knebel KD, Vasquez DA, Wilson CB (1976) In vivo clonogenic tumor cell kinetics following 1,3-bis(2-chloroethyl)-1-nitrosourea brain tumor therapy. Cancer Res 36(10):3718-3725
6. Barker M, Hoshino T, Gurcay O et al. (1973) Development of an animal brain tumor model and its response to therapy with 1,3-bis(2-chloroethyl)-1- nitrosourea. Cancer Res 33(5):976-986
7. Kim B, Chenevert TL, Ross BD (1995) Growth kinetics and treatment response of the intracerebral rat 9L brain tumor model: a quantitative in vivo study using magnetic resonance imaging. Clin Cancer Res 1(6):643-650
8. Ross BD, Chenevert TL, Kim B, Ben-Joseph O (1994) Magnetic resonance imaging and spectroscopy: application to experimental neuro-oncology. Q Magn Reson Biol Med 1:89-106
9. Ross BD, Chenevert TL, Rehemtulla A (2002) Magnetic resonance imaging in cancer research. Eur J Cancer 38(16):2147-2156
10. Ross BD, Moffat BA, Lawrence TS et al. (2003) Evaluation of cancer therapy using diffusion magnetic resonance imaging. Mol Cancer Ther 2(6):581-587
11. Stegman LD, Rehemtulla A, Hamstra DA et al. (2000) Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy. Gene Ther 7(12):1005-1010
12. Zhao M, Pipe JG, Bonnett J, Evelhoch JL (1996) Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo. Br J Cancer 73(1):61-64
13. Rehemtulla A, Hall DE, Stegman LD et al. (2002) Molecular imaging of gene expression and efficacy following adenoviral-mediated brain tumor gene therapy. Mol Imaging 1(1):43-55
14. Chenevert TL, Stegman LD, Taylor JM et al. (2000) Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 92(24):2029-2036
15. Chenevert TL, McKeever PE, Ross BD (1997) Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res 3(9):1457-1466
16. Brunberg JA, Chenevert TL, McKeever PE et al. (1995) In vivo MR determination of water diffusion coefficients and diffusion anisotropy: correlation with structural alteration in gliomas of the cerebral hemispheres. AJNR Am J Neuroradiol 16(2):361-371
17. Kauppinen RA (2002) Monitoring cytotoxic tumour treatment response by diffusion magnetic resonance imaging and proton spectroscopy. NMR Biomed 15(1):6-17
18. Hakumaki JM, Poptani H, Puumalainen AM et al. (1998) Quantitative 1H nuclear magnetic resonance diffusion spectroscopy of BT4C rat glioma during thymidine kinase-mediated gene therapy in vivo: identification of apoptotic response. Cancer Res 58(17):3791-3799
19. Galons JP, Altbach MI, Paine-Murrieta GD, Taylor CW, Gillies RJ (1999) Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. Neoplasia 1(2):113-117
20. Chenevert TL, Meyer CR, Moffat BA et al. (2002) Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy. Mol Imaging 1(4):336-343
21. Mardor Y, Pfeffer R, Spiegelmann R et al. (2003) Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging. J Clin Oncol 21(6):1094-1100
22. Mardor Y, Roth Y, Lidar Z et al. (2001) Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging. Cancer Res 61(13):4971-4973
23. Mori S, van Zijl PC (1995) Diffusion weighting by the trace of the diffusion tensor within a single scan. Magn Reson Med 33(1):41-52
24. Wong EC, Cox RW, Song AW (1995) Optimized isotropic diffusion weighting. Magn Reson Med 34(2):139-143
25. Pipe JG, Chenevert TL (1991) A progressive gradient moment nulling design technique. Magn Reson Med 19(1):175-179
26. Anderson AW, Gore JC (1994) Analysis and correction of motion artifacts in diffusion weighted imaging. Magn Reson Med 32(3):379-387
27. Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M (1986) MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 161(2):401-407
28. Stejskal EO, Tanner J (1965) Spin diffusion measurements: spin-echoes in the presence of a time-dependent field gradient. J Chem Phys 42:288-292
29. Hamstra DA, Tychewicz JM, Lee KC et al. (2004) 19F Spectroscopy and diffusion weight MRI predict increased tumor response to cytosine deaminase and uracil phosphoribosyl transferase gene dependent enzyme prodrug therapy. Mol Ther 10(5):916-928
30. Hall DE, Moffat BA, Stojanovska J et al. (2004) Therapeutic Efficacy of DTI-015 using diffusion MRI as an Early Surrogate Marker. Clin Cancer Res 10(23):7852-7859
31. James K, Eisenhauer E, Christian M et al. (1999) Measuring response in solid tumors: unidimensional versus bidimensional measurement. J Natl Cancer Inst 91(6):523-528
32. Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8(7):1277-1280
33. Ross BD, Chenevert TL, Garwood M et al. (2003) Evaluation of (E)-2′-deoxy-2′-(fluoromethylene)cytidine on the 9L rat brain tumor model using MRI. NMR Biomed 16(2):67-76